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Transcriptional Profiling Shows Altered Expression
of Wnt Pathway– and Lipid Metabolism–Related
Genes as Well as Melanogenesis-Related Genes
in Melasma
Hee Young Kang1,5, Itaru Suzuki2,5, Dong Jun Lee1, Jaehyun Ha3, Pascale Reiniche2, Je´roˆme Aubert2,
Sophie Deret2, Didier Zugaj2, Johannes J. Voegel2 and Jean-Paul Ortonne4
Melasma is a commonly acquired hyperpigmentary disorder of the face, but its pathogenesis is poorly
understood and its treatment remains challenging. We conducted a comparative histological study on lesional
and perilesional normal skin to clarify the histological nature of melasma. Significantly, higher amounts of
melanin and of melanogenesis-associated proteins were observed in the epidermis of lesional skin, and the
mRNA level of tyrosinase-related protein 1 was higher in lesional skin, indicating regulation at the mRNA level.
However, melanocyte numbers were comparable between lesional and perilesional skin. A transcriptomic study
was undertaken to identify genes involved in the pathology of melasma. A total of 279 genes were found to be
differentially expressed in lesional and perilesional skin. As was expected, the mRNA levels of a number of
known melanogenesis-associated genes, such as tyrosinase, were found to be elevated in lesional skin.
Bioinformatics analysis revealed that the most lipid metabolism-associated genes were downregulated in
lesional skin, and this finding was supported by an impaired barrier function in melasma. Interestingly, a subset
of Wnt signaling modulators, including Wnt inhibitory factor 1, secreted frizzled-related protein 2, and Wnt5a,
were also found to be upregulated in lesional skin. Immunohistochemistry confirmed the higher expression of
these factors in melasma lesions.
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INTRODUCTION
Melasma is a common acquired hyperpigmentary disorder
characterized by light- to dark-brown patches on the face
primarily caused by increased melanin deposition in the
epidermis (Kang et al., 2002; Grimes et al., 2005). Melano-
cytes within affected skin are larger, more dendritic, and
contain more melanosomes than melanocytes of unaffected
skin, which suggests that melanocytes are active in melasma.
These findings correlate well with the findings of an in vivo
reflectance confocal microscopic studies of melasma, which
have shown a significantly higher level of epidermal
pigmentation in lesional skin as compared with perilesional
normal skin (Kang et al., 2010).
The pathogenesis of melasma remains largely unknown
and its treatment challenging. A recent large-scale survey of
324 melasma-affected women suggested that a combination
of known triggers, such as, pregnancy, hormonal birth
control, a family history, and sun-exposure affect the onset
of melasma (Ortonne et al., 2009). Several histopathological
studies suggested that several protein factors and cellular
compartments have pathogenic roles. Im et al. (2002) found
that a-melanocyte-stimulating hormone (a-MSH) protein
levels are higher in melasma lesions, and Kang et al. (2006)
reported that stem cell factor expression from fibroblasts and
fibroblast numbers were higher in lesional skin. Furthermore,
Kim et al. (2007) showed that lesions tend to contain
more blood vessels, and suggested that vascular endothelial
growth factor promotes the prominent vascularization of
melasma lesions.
However, although several histological studies have been
performed on different protein markers, the pathogenesis
of melasma is far from being revealed. In the present study,
we performed large-scale gene expression profiling to
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investigate the pathogenesis of melasma. In the first part
of this study, histological analysis was performed to clarify
the nature of melasma and to justify a subsequent transcrip-
tomic study.
RESULTS
Histochemical and immunohistochemical evaluations and
in situ hybridization of TYRP1
Hematoxylin–eosin and Fontana–Masson staining were
performed to evaluate the general morphology of and
the quantity/distribution of melanin in the skin samples
(Figure 1a). Hematoxylin–eosin staining showed no signi-
ficant differences in general morphology between lesional
and perilesional skin. Fontana–Masson staining demonstrated
that epidermal melanin was markedly increased in lesional
skin. The melanin was concentrated in the basal layer, but
was also distributed throughout the epidermis. Dermal
melanin levels were too low to be of clinical significance.
Immunohistochemical staining was performed for tyrosinase
(TYR), tyrosinase-related protein 1 (TYRP1), dopachrome
tautomerase (DCT), silver (SILV), microphthalmia-associated
transcription factor (MITF), and SOX10 (Figure 1b). The levels
of TYR, TYRP1, DCT, and SILV, which are used as markers of
melanogenic activity, were higher in lesional skin (Figure 1c).
On the other hand, numbers of melanocytes, as determined
by the expressions of MITF and SOX10, were not significantly
different in lesional and perilesional skin (Figure 1c). TYRP1
in situ hybridization (ISH) was performed to determine
whether its elevated protein level in lesional skin was due
to an increase in its mRNA level (Figure 1d). In three patients,
the mRNA level of TYRP1 was elevated in lesional skin, but
in the other four, no significant difference was observed.
Nevertheless, these findings indicated that the increased
protein levels observed by immunohistochemistry (IHC) were
at least partly due to transcriptional increases, which
reinforces the importance of performing transcriptomic
analysis and the use of TYRP1 as a positive control.
Identification of genes differentially expressed in lesional skin
Biostatistical analysis of 10 paired samples showed that
131 probe sets were differentially expressed in lesional and
perilesional skin. Furthermore, hierarchical clustering ana-
lysis of these 131 probe sets separated lesional and peri-
lesional samples, and revealed the existence of two
subgroups of samples (Figure 2). The gene expression of
one subgroup of six patients was more affected than those of
the other four patients. In addition, this transcriptomic
classification was found to be well correlated with clinical
data (delta L values: data not shown). A second statistical
analysis of the six paired samples identified 339 probe sets
(279 genes) to be differentially expressed in lesional
and perilesional skin (fold modulation of 41.4 or o0.71,
Po0.05); 187 probe sets were upregulated and 152 probe
sets downregulated in lesional skins. The 20 most up- and
downregulated probe sets are listed in Table 1, and as was
expected based on our IHC and ISH results, the melanogen-
esis-associated genes (SILV, TYRP1, melan-A (MLANA), TYR)
were included in our upregulated genes list. The upregulated
genes included WNT inhibitory factor 1 (WIF1), which is
an antagonist of Wnt signaling (Kawano et al., 2003) and
leucine-rich repeat-containing G protein-coupled receptor 5,
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Figure 1. Histochemical/immunohistochemical evaluations and messenger
RNA levels of tyrosinase-related protein 1 (TYRP1). (a) Hematoxylin–eosin
(HE) staining showed no major difference in the general morphology or
cytology of skin samples. Fontana–Masson (FM) staining showed an obvious
increase in epidermal melanin in lesional skin. In these subjects, we
did not observe significant amounts of dermal melanin (bar¼100 mm).
(b) Melanogenesis-associated factors (tyrosinase (TYR), TYRP1, dopachrome
tautomerase (DCT), and silver (SILV)) and melanocyte-specific transcription
factors (microphthalmia-associated transcription factor (MITF) and SOX10)
were evaluated by immunohistochemistry. TYR is stained red and the other
proteins are stained blue (see color figure online). The melanogenesis-
associated factors were found to be upregulated in lesional skin
(bar¼ 100 mm). (c) Numbers represent fold increases in lesional skin as
compared with perilesional skin of same patients as determined by image
analysis. Image analysis results corresponded well with visual assessments.
Interestingly, numbers of melanocytes determined by MITF and SOX10
immunostaining were not significantly different. (d) Signals were observed
in cells in the basal layer epidermis corresponding to the distribution of
melanocytes. The mRNA levels of TYRP1 were elevated in lesional skin
(bar¼ 100 mm).
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which is involved in Wnt signaling as a Wnt target gene
(Garcia et al., 2009). Genes known to be involved in
fibroblast and keratinocyte proliferation, namely, cartilage
oligomeric matrix protein (COMP), insulin-like growth factor-
binding protein 3 (IGFBP3), and serpin peptidase inhibitor,
clade B (ovalbumin) member 3 (also known as SCCA1; Enk
et al., 2004; Edmondson et al., 2005; Hesselstrand et al.,
2008) were also among the top 20 upregulated genes.
Bioinformatics analysis: gene ontology and biological pathways
We performed gene ontology analysis using the web-based
application GOTM (http://bioinfo.vanderbilt.edu/gotm/) on
the 279 differentially expressed genes. Melanin biosynthesis,
lipid metabolism, and prostaglandin metabolism were
identified as the most affected biological processes (Table 2).
All four genes involved in melanin biosynthesis (TYR, TYRP1,
DCT, and SILV) were upregulated. Whereas, most of the lipid
metabolism associated genes, such as PPARA, arachidonate
15-lipoxygenase, type B, diacylglycerol O-acyltransferase2-
like 3, and PPAR gamma coactivator 1 alpha, were down-
regulated. Notably, prostaglandin-endoperoxide synthase 1,
a key participant in prostaglandin synthesis, was upregulated.
A literature-based molecular network analysis on the
279 differentially expressed genes identified the MITF-
associated pathway as the most significantly modified
pathway. All of the following clustered members of this
pathway were upregulated: MITF, transient receptor potential
cation channel, subfamily M, member 1, paired box 6,
empty spiracles homeobox 2, SILV, TYRP1, MLANA, and
TYR (Supplementary Figure S1 online). A matrix metallo-
peptidase (MMP2)-related pathway, including MMP2,
endothelin-3, and endothelin receptor B (1.46-, 1.41-, and
1.38-fold inductions, respectively), was also identified.
Furthermore, a subset of Wnt pathway modulator genes,
i.e., WIF1, secreted frizzled-related protein 2 (SFRP2), and
WNT5a, were found to be significantly upregulated in
lesional skin (2.87-, 1.76-, and 1.44-fold inductions, respec-
tively). Although their fold changes did not reach our cutoff
thresholds, the mRNA levels of Dickkopf (DKK)1, DKK2,
and DKK3 were also slightly increased (by 1.22-, 1.35-, and
1.23-fold, respectively).
Barrier recovery was delayed in lesional skin
To further investigate the involvements of lipid metabolism-
related genes in melasma, we measured the barrier functions
of lesional and perilesional skins by measuring transepider-
mal water losses (TEWLs; Figure 3). Basal TEWL (Tbase) values
of lesional skins did not differ significantly from those of
perilesional skins (13.5±4.0 vs. 15.6±4.6, P¼ 0.210). How-
ever, TEWL values after barrier perturbation were signifi-
cantly higher for lesional skins (79.5±40.9% vs. 143.2±
116.4%, P¼0.014). A significantly delayed barrier recovery
rate was demonstrated by lesional skins (76.3±12.3% vs.
62.5±22.8%, P¼ 0.043).
Immunohistochemistry for Wnt signaling-associated factors
We performed IHC for the Wnt signaling-associated factors
(WIF1, SFRP2, and WNT5a) to determine their distributions
and expression levels in normal skin (Figure 4). WIF1
was found to be faintly expressed in the basal layer of the
epidermis, whereas SFRP2 was distributed in all layers of the
epidermis in a mosaic pattern. Wnt5a was also expressed in
the epidermis. Interestingly, melanocytes were positive for
WIF1 and Wnt5a, and dermal fibroblasts and endothelial
cells were positive for all three proteins. In the five of eight
patients, the protein levels of WIF1 were stronger in the
melanocytes of lesional skin samples than in those of
perilesional skin samples (Figure 4a and b). Furthermore,
SFRP2 immunoreactivity around dermal fibroblasts seemed to
be higher in the lesional skin (Figure 4c and d), and Wnt5a
immunoreactivity was also higher in the basal layer and
around fibroblasts in lesional skin (Figure 4e and f). Taken
together, the expressions of WIF1, SFRP2, and WNT5a
protein were upregulated in lesional skin.
DISCUSSION
This study demonstrates that increased epidermal pigmenta-
tion is the main physiopathological observation in melasma
affected. The protein levels of melanogenesis-associated
factors (TYR, TYRP1, DCT, and SILV) were increased in
melasma lesions, indicating higher melanogenic activity in
lesional skin. The amount of dermal melanin observed
was too low to be of clinical significance, which concurs
with previous reports that epidermal hyperpigmentation is the
hallmark of melasma (Kang et al., 2002, 2010; Grimes et al.,
2005). Also, it should be considered that dermal melanin is
commonly found in normal facial skin as well as melasma in
skin types III to V. Considering our patients were Caucasian, it
is not surprising they had little dermal melanin.
The numbers of melanocytes were not significantly
increased in melasma. As melanocytes are dendritic cells,
the use of cytoplasmic proteins, such as TYR and TYRP1, as
markers for counting melanocytes can be misleading. In the
present study, we used two nuclear markers of melanocytes
(MITF and SOX10) to count melanocytes to avoid this
problem. The results obtained with these markers were
consistent, which indicates that numbers of melanocytes are
no different in melasma lesions. These results show that the
increased epidermal melanin observed in melasma lesions is
due to increased melanogenesis in individual melanocytes
Perilesional
normal skin
Lesional
skin
Figure 2. Hierarchical clustering. Hierarchical clustering analysis was
performed on 131 probe sets found to be differentially expressed in
lesional and perilesional skin. The results obtained revealed the existence
of two subgroups, in which one subgroup of six patients (box) was more
affected in terms of gene expressional changes than the other subgroup
(four patients). Red and blue (see color figure online) represent up- and
downregulated genes, respectively.
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Table 1. The 20 most up- and downregulated genes ranked according to mean value
Probe set Gene symbol Gene title UNIGENE
Fold induction
(geometric mean)
(A) Upregulated
224209_s_at GDA Guanine deaminase Hs.494163 3.087
209848_s_at SILV Silver homolog (mouse) Hs.95972 3.040
205694_at TYRP1 Tyrosinase-related protein 1 Hs.270279 2.881
204712_at WIF1 WNT inhibitory factor 1 Hs.284122 2.871
1553081_at WFDC12 WAP four-disulfide core domain 12 Hs.352180 2.853
235795_at PAX6 Paired box 6 Hs.591993 2.747
205229_s_at COCH Coagulation factor C homolog, cochlin (Limulus polyphemus) Hs.21016 2.635
213568_at OSR2 Odd-skipped-related 2 (Drosophila) Hs.253247 2.535
209719_x_at SERPINB3 Serpin peptidase inhibitor, clade B (ovalbumin), member 3 Hs.227948 2.498
209720_s_at SERPINB3 Serpin peptidase inhibitor, clade B (ovalbumin), member 3 Hs.227948 2.412
1554242_a_at COCH Coagulation factor C homolog, cochlin (Limulus polyphemus) Hs.21016 2.332
205713_s_at COMP Cartilage oligomeric matrix protein Hs.1584 2.277
206643_at HAL Histidine ammonia-lyase Hs.190783 2.233
206177_s_at ARG1 Arginase, liver Hs.440934 2.229
206426_at MLANA Melan-A Hs.154069 2.085
206630_at TYR Tyrosinase (oculocutaneous albinism IA) Hs.503555 2.027
213880_at LGR5 Leucine-rich repeat-containing G protein-coupled receptor 5 Hs.658889 2.009
206140_at LHX2 LIM homeobox 2 Hs.696425 1.997
206427_s_at MLANA Melan-A Hs.154069 1.966
210095_s_at IGFBP3 Insulin-like growth factor-binding protein 3 Hs.450230 1.953
(B) Downregulated
239272_at MMP28 Matrix metallopeptidase 28 Hs.380710 0.714
236035_at — Transcribed locus Hs.435027 0.714
223437_at PPARA Peroxisome proliferator-activated receptor alpha Hs.103110 0.714
203972_s_at PEX3 Peroxisomal biogenesis factor 3 Hs.7277 0.713
218552_at ECHDC2 Enoyl Coenzyme A hydratase domain containing 2 Hs.476319 0.712
209048_s_at ZMYND8 Zinc finger, MYND-type containing 8 Hs.446240 0.712
226560_at — Transcribed locus Hs.210043 0.711
238567_at SGPP2 Sphingosine-1-phosphate phosphatase 2 Hs.591604 0.709
221942_s_at GUCY1A3 Guanylate cyclase 1, soluble, alpha 3 Hs.24258 0.708
213935_at ABHD5 Abhydrolase domain containing 5 Hs.655670 0.708
210512_s_at VEGFA Vascular endothelial growth factor A Hs.73793 0.707
228221_at SLC44A3 Solute carrier family 44, member 3 Hs.483423 0.706
225726_s_at PLEKHH1 Pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 Hs.594236 0.703
225728_at SORBS2 Sorbin and SH3 domain containing 2 Hs.655143 0.703
206605_at P11 26 Serine protease Hs.997 0.703
217523_at CD44 CD44 molecule (Indian blood group) Hs.502328 0.703
225755_at KLHDC8B Kelch domain containing 8B Hs.13781 0.703
229147_at — Transcribed locus Hs.529677 0.703
212463_at CD59 CD59 molecule, complement regulatory protein Hs.278573 0.702
240038_at — Transcribed locus Hs.608694 0.702
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rather than to an increase in the number of pigment-
producing cells.
In the present study, 279 genes were found to be
modulated in lesional skin. The degrees of these expressional
changes were relatively small, which is not surprising
considering the immunohistochemical and clinical charac-
teristics of melasma. Importantly, we identified four upregu-
lated melanogenesis-associated genes, including our positive
control TYRP1, in lesional skin. Of particular interest, we
found that a subset of Wnt pathway modulators (Wnt5a,
SFRP2, and WIF1) were upregulated in lesional skin. The Wnt
pathway has a critical role in the development of epidermal
melanocytes, and MITF is a nuclear mediator of this pathway
(Takeda et al., 2000; Chien et al., 2009). However, the roles
of Wnt proteins and of secreted Wnt inhibitors on cutaneous
pigmentation are largely unknown, although a microarray
analysis of solar lentigo identified the upregulation of the
SFRP1 gene (Goyarts et al., 2007). Furthermore, a transcrip-
tomic study using palmoplantar skin fibroblasts demonstrated
the differential expression of DKK1, an inhibitor of Wnt
signaling pathway (Yamaguchi et al., 2009). The findings of
these studies suggest that modulation of the Wnt signaling
pathway might be involved in the pathogenesis of pigmentary
disorders. Our transcriptomic study showed that WIF1,
SFRP2, and Wnt5a were upregulated in melasma lesions,
and WIF1 was one of the 20 most upregulated genes.
Interestingly, our immunohistochemical analysis demon-
strated that WIF1 and Wnt5a proteins were expressed in
melanocytes, suggesting that they have a role in melano-
cyte biology and melanogenesis. The increased SFRP2
Table 2. The functional classes of differentially expressed genes
Putative function P-value Gene symbol Gene title
Fold induction
(geom. mean)
Melanin biosynthetic process 1.2 106 DCT Dopachrome tautomerase (tyrosine-related protein 2) 1.646
SILV Silver homolog (mouse) 3.040
TYR Tyrosinase 2.027
TYRP1 Tyrosinase-related protein 1 2.881
Lipid metabolic process 2.5 105 DHRS9 Dehydrogenase/reductase (SDR family) member 9 0.598
EBP Emopamil-binding protein (sterol isomerase) 0.683
PPARGC1A Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 0.688
SLC27A2 Solute carrier family 27 (fatty acid transporter), member 2 0.590
DGAT2L3 Diacylglycerol O-acyltransferase 2-like 3 0.575
ALOX15B Arachidonate 15-lipoxygenase, type B 0.480
HACL1 2-Hydroxyacyl-CoA lyase 1 0.672
HMGCS1 3-Hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) 0.667
HMGCS2 3-Hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) 0.676
HPGD Hydroxyprostaglandin dehydrogenase 15-(NAD) 1.449
HSD11B1 Hydroxysteroid (11-beta) dehydrogenase 1 0.616
ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain 0.678
MVD Mevalonate (diphospho) decarboxylase 0.680
RDH11 Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) 0.668
PPARA Peroxisome proliferator-activated receptor alpha 0.714
PPARA Peroxisome proliferator-activated receptor alpha 0.695
PECR Peroxisomal trans-2-enoyl-CoA reductase 0.625
ACSS2 Acyl-CoA synthetase short-chain family member 2 0.643
PTGIS Prostaglandin I2 (prostacyclin) synthase 1.387
PTGS1 Prostaglandin-endoperoxide synthase 1 1.480
PTGS1 Prostaglandin-endoperoxide synthase 1 1.542
SULT1E1 Sulfotransferase family 1E, estrogen-preferring, member 1 1.833
Prostaglandin metabolic process 1.9 103 PTGIS Prostaglandin I2 (prostacyclin) synthase 1.387
PTGS1 Prostaglandin-endoperoxide synthase 1 1.480
PTGS1 Prostaglandin-endoperoxide synthase 1 1.542
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immunoreactivity observed around fibroblasts in lesional
dermis also suggested the possibility of cross talk between the
dermis and epidermis via the Wnt pathway during the
development of melasma. Further studies are necessary to
elucidate the role of Wnt signaling modulators in cutaneous
pigmentation.
Our bioinformatics analysis identified significant modifi-
cations of lipid metabolism-related genes in melasma. Also,
we found that the barrier function of lesional skin is easily
damaged and that it has a delayed recovery rate as compared
with perilesional skin. The mechanisms underlying this
abnormal barrier function in melasma are not clear, but it is
well known that lipids of the stratum corneum have an
important role in barrier homeostasis, and thus, the down-
regulation of lipid genes in melasma may be related to an
impaired barrier function. Furthermore, previous studies have
demonstrated that chronic UV exposure, which is an
aggravating factor in melasma, influences cutaneous fatty
acid metabolism and skin barrier function (Merle et al.,
2010). Therefore, an altered barrier function in melasma
might be a result of the chronic UV exposure and accom-
panying epidermal hyperpigmentation. Interestingly, recent
studies have demonstrated that barrier function is also
influenced by pigmentation (Gunathilake et al., 2009). The
biological role of lipid metabolism in the pathogenesis of
melasma remains an interesting topic for future study.
Furthermore, improvement in epidermal barrier function may
be an unrecognized factor to be considered in treating melasma.
Prostaglandin biosynthesis is also significantly modified in
the lesional skin of melasma. Prostaglandins are synthesized
in the skin in response to UV exposure, and are known to
affect melanogenesis (Rhodes et al., 2009). It has also been
clinically documented that prostaglandin analogs induce
epidermal hyperpigmentation (Kapoor et al., 2009). Interest-
ingly, gene expression profiling analysis of solar lentigo
demonstrated the upregulations of genes related to fatty acid
metabolism, which suggested the activation of the arachi-
donic acid pathway (Aoki et al., 2007).
UV exposure is believed to be an aggravating factor in
melasma, and previous studies have indicated that melasma
lesions show a higher degree of UV-induced damage, similar
to solar elastosis (Herna´ndez-Barrera et al., 2008). In the
present study, we noted that the expressions of some genes
previously demonstrated to be associated with UV exposure
were altered in lesional skin. These genes include MITF and
the melanogenesis-associated genes TYR, TYRP1, and DCT,
which were all found to be upregulated in UV-irradiated
human skin in vivo (Suzuki et al., 2002). SCCA1, which was
found to be increased in human epidermis following UVB
exposure (Enk et al., 2004), was also found to be increased in
the present study. Furthermore, the redistribution of melano-
somes along dendrites and their subsequent transfer to
keratinocytes is a known UVR response (Boissy, 2003).
The expression of myosin 5a), a genes involved in melano-
some movement, was increased in lesional skin. Interestingly,
the well-known keratinocyte-derived growth factors of
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Figure 3. Comparison of the barrier functions of lesional and perilesional skins. (a) Basal transepidermal water loss (TEWL) was not significantly
different in lesional and perilesional skins. (b) TEWL values after barrier perturbation were significantly higher for lesional skin. (c) A significantly delayed
barrier recovery rate was demonstrated by lesional skin. *Po0.05.
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Figure 4. Immunohistochemical staining of Wnt signaling-associated
factors. WNT inhibitory factor 1 (WIF1), secreted frizzled-related protein 2
(SFRP2), and Wnt5a were immunohistochemically detected using specific
antibodies. Protein levels of WIF1 were greater in melanocytes of lesional skin
(a) than in those of perilesional skin (b). SFRP2 immunoreactivity around
fibroblasts in the dermis seemed to be greater in lesional skin than in
perilesional skin (c, d). Wnt5a showed greater expression in the basal layer
and around fibroblasts in lesional skin (e) than in perilesional skin (f)
(bar¼ 200 mm).
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melanocytes, such as pro-opiomelanocortine (precursor of
MSHs and ACTH), endothelin 1, and basic fibroblast growth
factor, which are induced by acute UV exposure, did not
exhibit any significant mRNA changes in lesional skin.
Furthermore, the expression of the hallmark UV-responsive
gene, p53, was unchanged in melasma lesions, which is
consistent with the finding that UVR-induced p53 protein
increases are principally due to post-translational stabiliza-
tion rather than transcriptional regulation (Yang et al., 2006).
Recent studies have suggested the involvements of dermal
factors in the pathogenesis of melasma (Kang et al., 2006;
Kim et al., 2007). In the present study, we observed the
upregulation of several angiogenesis-related genes, such as
angiopoietin-like 1 and 2, heparanase, and MMP2 in lesional
skin. However, one of the major angiogenesis-inducing
factor, vascular endothelial growth factor, was downregu-
lated. Furthermore, COMP and IGFBP3, which have been
detected by gene expression profiling studies of fibroproli-
ferative disorders (Hesselstrand et al., 2008; Smith et al.,
2008), were present on our top 20 upregulated genes list.
However, the biological roles played by these genes in
cutaneous pigmentation are unknown.
It is also believed that sex hormones such as estrogen are
involved in the pathogenesis of melasma, and therefore, we
expected to observe the upregulations of sex hormones or sex
hormone metabolism-related genes. However, in the event
only one gene, estrogen sulfotransferase 1E, member 1, a
major contributor to beta estradiol inactivation, was present
on our upregulated genes list.
It was noted that in the present study, gene expression
levels were variable in the skin samples, even for the
melanogenesis-associated genes. It have been previously
reported that some melasma patients have hyperactive
melanocytes, which suggests that the statuses of melanocytes
differ in melasma patients (Kang et al., 2010). This finding
requires further investigation as it might help to explain
why patients respond differently to the standard melasma
treatment.
In conclusion, our results show that in melasma lesions,
melanogenesis in melanocytes is activated at least partially at
the transcriptional level. Furthermore, we identified several
signaling pathways, including the Wnt signaling and lipid
metabolism pathways, potentially involved in the develop-
ment of melasma lesions. Furthermore, our study provides
a first transcriptomic data set for melasma, which should
be useful for those attempting to elucidate the pathogenesis
of this disease.
MATERIALS AND METHODS
Patients and study design
This study was approved by the South Mediterranean human subject
protection committee (Comite´ de Protection des Personnes Sud
Me´diterrane´e II) and by the Institutional Review Board at Ajou
University Hospital and was conducted in accordance with the latest
revision of the Declaration of Helsinki Principles. For the histological
study, skin biopsies were obtained from 10 Caucasian melasma
patients of mean age 39.5 years (range 33–47 years). Three patients
were eliminated from analyses because of an inadequate melanin in
lesional skin. For the transcriptomic study, 12 Korean melasma
patients of mean age 43 years (range 30–50 years) were enrolled. An
additional set of eight Korean melasma patients were recruited for
the immunohistochemical staining of factors identified during the
transcriptomic analysis. Another 16 Korean melasma patients were
recruited (mean age 44 years; range 31–55 years) to measure skin
barrier functions. Informed consent was obtained from all subjects.
Exclusion criteria included use of medication for the treatment of
melasma and facial diseases including acne and wrinkles during the
previous 3 months, the use of steroid containing agents, bleaching
products, or retinoic acid-containing agents, any UV or physical
therapy (including lasers, dermabrasion, and chemical peeling)
during the previous 3 months, or a positive reaction for hepatitis B,
C, and HIV. Colors of lesional or perilesional skin were measured
using a colorimeter (Chromameter CR300, Minolta, Tokyo, Japan).
Two-millimeter punch biopsies from lesional and perilesional
normal facial skin (usually within 1 cm away from the lesional
border, referred to as perilesional skin) were obtained from each
patient under local anesthesia.
Histochemistry/immunohistochemistry and in situ
hybridization
Hematoxylin–Eosin staining and Fontana–Masson staining were
performed using standard protocols. The following antibodies
were used for the immunohistochemical evaluation of proteins;
TYR (Novocastra, Newcastle upon Tyne, UK), TYRP1 (Novocastra,
Wetzlar, Germany), DCT (Santa Cruz Biotechnology, Santa Cruz,
CA), SILV, MITF (both from Novocastra, Wetzlar, Germany), SOX10
(Santa Cruz Biotechnology), WIF1 (1:10 dilution; R&D Systems,
Minneapolis, MN), SFRP2 (1:30; Sigma Chemical, St Louis, MO),
and Wnt5a (Abcam, Cambridge, MA). IHC was performed
using a Discovery XT (Ventana, Tucson, AZ) following the
manufacturer’s protocol for TYR, TYRP1, DCT, SILV, MITF, and
SOX10; WIF1, SFRP2, and Wnt5a were detected using a biotinylated
secondary antibody and AEC chromogen (Immunogen, Pittsburgh,
PA). A DIG-labeled RNA probe against TYRP1 was created by
in vitro transcription following a standard protocol. ISH was
performed using the Discovery XT (Ventana) using a standard
protocol. The images were analyzed using MatLab (MathWorks,
Natick, MA).
RNA extraction
A total of 12 matched tissue pairs were immediately frozen in liquid
nitrogen. Tissue lysates were homogenized using QIAshredder
columns (Qiagen, Valencia, CA) and total RNA samples were
obtained using RNeasy micro-kits (Qiagen, Hilden, Germany).
DNase I treatment (27 U, 15 minutes) of total RNA was performed
directly on the spin columns to eliminate genomic DNA contamina-
tion. RNA quantification was performed using the Quant-it Ribo-
green RNA assay kit (Molecular Probes, Eugene, OR) and the quality
was monitored by following electrophoresis behavior using an
Agilent Bioanalyzer 2100 system (Agilent Technologies, Palo Alto,
CA). Extracted RNA (50 ng) of good quality (RNA integrity number
X7) was then used for probe synthesis.
Affymetrix probe synthesis and hybridization
Total RNA (50 ng) from each sample was used to generate double-
stranded complementary DNA (cDNA) using a T7-oligo (dt) primer
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(Two cycle cDNA synthesis kit, Affymetrix, Santa Clara, CA). This
cDNA was then used to produce complementary RNA (cRNA) using
an in vitro transcription kit MEGAscript T7 (Ambion, Austin, TX).
cRNA (600 ng) was used for the second round of double-stranded
cDNA synthesis (Two cycle cDNA synthesis kit, Affymetrix). The
cDNA so obtained was then used to produce biotinylated cRNA
using the in vitro transcription Gene Chip IVT labelling kit
(Affymetrix). Biotinylated cRNA (20 mg) was fragmented and
fragmented cRNA (15 mg) was hybridized to an Affymetrix human
U133A 2.0 plus microarray (Affymetrix). Arrays were processed on a
Gene Chip Fluidics Station 450 and scanned on an Affymetrix Gene
Chip Scanner 3000 (Affymetrix). Raw data were analyzed using a
GeneChip Expression Consol (Affymetrix) using the robust multi-
array average method. The skin samples of two patients did not pass
quality controls, and were excluded from further analysis, which was
performed using 10 paired samples.
Statistical analysis
Probe sets with at least two in four insignificant calls were
disregarded, which resulted in 27,642 of 54,675 probe sets being
considered for the statistical analysis. For each subject, the mean
expression ratio of lesional to perilesional samples was subtracted
from each of the four expression values measured on each probe set
to cancel inter-individual validations. The Student’s t-test was
applied on subject-corrected expression values along with
Benjamini–Hochberg adjustment for multiplicity testing. The first
statistical analysis of 10 paired samples showed that 131 probe sets
were differentially expressed in lesional and perilesional skin.
Hierarchical clustering was performed on these 131 probe sets and
identified a subgroup of six patients who were more strongly affected
in terms of gene expressional changes than the other four patients.
A second statistical analysis on the six paired samples identified
339 probe sets. The 339 probe sets were used for bioinformatics
analysis.
Bioinformatics analysis
GOTM (http://bioinfo.vanderbilt.edu/gotm/), a gene ontology enrich-
ment analysis tool, was used to obtain biologically meaningful
information based on gene lists (Zhang et al., 2004). This tool
compares a user-uploaded gene list with all gene ontology categories
to identify those with an enriched number of user-uploaded genes. The
result is visualized in a directed acyclic graph in order of maintaining
relationship among the enriched gene ontology categories.
To investigate possible biological interactions of differentially
regulated genes, the gene lists derived by statistical analyses
were exported into the Ingenuity Pathway Analysis Tool (IPA Tool;
Ingenuity Systems, Redwood City, CA; http://www.ingenuity.com).
Skin barrier function
The basal TEWL was measured on both lesional and non-lesional skin
using a Tewameter probe (TM210; connected to MPA-5, Coura-
geþKhazaka Electronic GmbH, Ko¨ln, Germany). To determine barrier
recovery rates, barrier perturbation was performed five times by
repeated tape stripping (D-Squame), and TEWL values were measured
immediately (Timm) and 5 hours after barrier perturbation (T5hours).
Barrier recovery rates were calculated using (TimmT5hours)/
(TimmTbase) 100. All subjects rested for 30 minutes in the 24–26 1C/
50–55% RH testing environment before basal TEWL was measured.
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